Apex Medical was built on a simple premise: medtech companies deserve advisors who have actually carried the quota, built the team, and launched the product.
With over two decades of senior leadership across medical devices, diagnostics, and digital health, Mark brings a rare combination of clinical insight, commercial rigour, and a deep North American network to every engagement.
Holding a B.Sc., a Doctor of Chiropractic, and an MBA in Strategy and Marketing from the Schulich School of Business, Mark has served as Principal Consultant, Chief Revenue Officer, and VP of Sales and Marketing — giving Apex Medical an operator's perspective that pure advisory firms cannot replicate.
His work spans the full commercialization continuum — from early-stage market assessment through product launch, sales team development, funding support, and M&A — across the US and Canadian markets, with growing engagement from PE/VC firms and family offices. He is currently developing funding submissions in injury-prevention medtech and actively engaging companies innovating in that space.
MBPrincipal Consultant & Founder
B.Sc. · D.C. · MBA (SCHULICH)
20+ YEARS · NORTH AMERICAN MEDTECH
Trained and practiced as a Doctor of Chiropractic — building the clinical fluency that lets Apex speak credibly with surgeons, specialists, and KOLs.
Led device sales and marketing organizations — recruiting, structuring, and scaling teams, and owning revenue in competitive North American markets.
Full commercial accountability across devices, diagnostics, and digital health — pricing, channels, launches, and the P&L behind them.
Strategy and Marketing specialization — layering formal strategic frameworks over hard-won operating experience.
Advising device innovators, established manufacturers, and investors across the full commercialization continuum — amplified with AI-enabled intelligence tools, and with an active focus on funding and commercializing injury-prevention medtech.
Every recommendation is grounded in market data, procedure economics, and regulatory reality — not what a client hopes to hear.
The US and Canada reward different approaches. Treating them as one market wastes money; treating them as unrelated wastes time. We sequence them deliberately.
A roadmap without hands-on implementation is a PDF. Apex stays engaged through launch — KOL programs, team building, and market development included.